sorafenib has been researched along with Pancreatic Diseases in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, MS; Li, SP; Pawlik, TM; Spolverato, G; Xu, L; Zhang, YJ; Zhao, J; Zhou, DS | 1 |
1 other study(ies) available for sorafenib and Pancreatic Diseases
| Article | Year |
|---|---|
Long-term therapy with sorafenib is associated with pancreatic atrophy.
Topics: Aged; Antineoplastic Agents; Atrophy; Carcinoma, Hepatocellular; China; Cohort Studies; Female; Humans; Liver Neoplasms; Male; Middle Aged; Niacinamide; Pancreas; Pancreatic Diseases; Phenylurea Compounds; Sorafenib; Treatment Outcome | 2015 |